echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Review of Shanghai Pharmaceutical Cimetidine Tablets and Perindopril Tert-butylamine Tablets

    Review of Shanghai Pharmaceutical Cimetidine Tablets and Perindopril Tert-butylamine Tablets

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 12, Shanghai Pharmaceuticals issued an announcement stating that its wholly-owned subsidiary received the "Notice of Approval of Supplementary Application for Drugs" issued by the State Food and Drug Administration regarding cimetidine tablets and perindopril tert-butylamine tablets (4mg, 2mg) , The above-mentioned drugs have passed the quality and efficacy consistency evaluation of generic drugs.


    Cimetidine tablets are mainly used to relieve stomach pain, heartburn (heartburn), and acid reflux caused by hyperacidity.


    Perindopril tert-butylamine tablets are mainly used for hypertension and congestive heart failure.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.